CRL
Charles River Laboratories International, Inc. · Healthcare · Medical - Diagnostics & Research
Momentum-Eingaben (vergleichbare Manager):
Halterbreite +11.1% ·
Aktienfluss +11.8% ·
neue Nettopositionen +10.0%
— Formel
Breite Akkumulation — steigende Anteile bei mehr Haltern
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q2 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 140 | -1 | 45.53M | $10.31B | +6 | −6 |
| Q1 2026 | 143 | -7 | 45.52M | $7.86B | +6 | −14 |
| Q4 2025 | 150 | +3 | 43.69M | $8.72B | +4 | — |
| Q3 2025 | 22 | 0 | 23.18M | $3.62B | +1 | −2 |
| Q2 2025 | 20 | +2 | 21.36M | $3.24B | +4 | −2 |
| Q1 2025 | 15 | 0 | 9.57M | $1.44B | +1 | −1 |
| Q4 2024 | 15 | +1 | 9.65M | $1.78B | +1 | — |
| Q3 2024 | 13 | -1 | 6.67M | $1.31B | — | −1 |
| Q2 2024 | 14 | — | 3.92M | $810.09M | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passiv) | 5.81M | — | $881.82M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 2 | Wellington Management ✦ | 3.77M | -12.1% | $571.69M | 0.1% | ▼ Trim | 5 | SEC ↗ ×8 |
| 3 | BlackRock ✦ (passiv) | 3.66M | — | $554.74M | 0.0% | n/c | 1 | SEC ↗ ×18 |
| 4 | State Street Global Advisors ✦ (passiv) | 1.86M | -2.3% | $282.03M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passiv) | 1.23M | -2.5% | $186.60M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 6 | Harris Associates (Oakmark) ✦ | 1.16M | Neu | $176.45M | 0.3% | New | 1 | SEC ↗ |
| 7 | D. E. Shaw & Co. ✦ | 607.02K | Neu | $92.10M | 0.1% | New | 1 | SEC ↗ ×2 |
| 8 | Arrowstreet Capital ✦ | 578.61K | +63.6% | $87.79M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 9 | Citadel Advisors ✦ | 564.59K | +100.2% | $85.67M | 0.1% | ▲ Add | 5 | SEC ↗ ×2 |
| 10 | Millennium Management ✦ | 507.32K | +580.9% | $76.98M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 11 | Norges Bank ✦ (passiv) | 507.16K | +15.8% | $76.95M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 12 | PRIMECAP Management ✦ | 270.60K | -0.8% | $41.06M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 13 | Gotham Asset Management ✦ | 269.16K | +73.9% | $40.84M | 0.2% | ▲ Add | 5 | SEC ↗ |
| 14 | Point72 Asset Management ✦ | 236.41K | Neu | $35.87M | 0.1% | New | 1 | SEC ↗ |
| 15 | Two Sigma Investments ✦ | 93.67K | -42.6% | $14.21M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 16 | Fidelity (FMR) ✦ | 78.32K | — | $11.88M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 17 | T. Rowe Price ✦ | 74.47K | -2.0% | $11.30M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 18 | Adage Capital Partners ✦ | 45.00K | Neu | $6.83M | 0.0% | New | 1 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 26.76K | +329.1% | $4.02M | 0.0% | ▲ Add | 5 | SEC ↗ ×5 |
| 20 | Marshall Wace ✦ | 14.07K | -62.9% | $2.14M | 0.0% | ▼ Trim | 5 | SEC ↗ ×3 |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Harris Associates (Oakmark) | $176.45M | 0.3% |
| D. E. Shaw & Co. | $92.10M | 0.1% |
| Point72 Asset Management | $35.87M | 0.1% |
| Adage Capital Partners | $6.83M | 0.0% |
Ausgestiegen
| Fisher Asset Management | $38.42M | war 0.0% |
| Baillie Gifford | $7,375 | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 555 Inhaber, 56.84M Anteile, $9.32B gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.
Käufe auf dem offenen Markt (P)
Officer · EVP & Chief Financial… · 10 Ant. @ 297.43 · $2,974
Verkäufe auf dem offenen Markt (S)
Officer · 981 Ant. · $302,580
Director · 33.56K Ant. · $10.07M
Officer · 2.04K Ant. · $599,711
Director · 573 Ant. · $163,443
Officer, Director · 6.50K Ant. · $1.82M
Officer · 3.71K Ant. · $1.04M
Director · 28.73K Ant. · $7.90M
Officer · 620 Ant. · $163,643
Officer · 482 Ant. · $127,812
Officer · 404 Ant. · $104,446
Zuteilungen, Ausübungen und Steuereinbehalte werden hier nie als Käufe oder Verkäufe gezählt. Methodik